EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudie

Stage shift, histological differentiation, and survival patterns of lung squamous cell carcinoma versus adenocarcinoma in low-dose CT screening

Yaguang Fan, Ying Wang, Xuebing Li, Heng Wu, Hongli Pan, Yong Jiang, Zhaowei Meng, Jing Wang, Jun Chen, Qinghua Zhou, Youlin Qiao

Cancer Epidemiology · 2026

DOI: 10.1016/j.canep.2026.103197 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Cancer Epidemiology, 2026. Verfasst von Yaguang Fan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Tianjin Lung Cancer Institute, Tianjin Medical University General Hospit…. Hauptthemen laut MEDLINE: Lung Neoplasms, Carcinoma, Squamous Cell, Tomography, X-Ray Computed, Adenocarcinoma. Die Arbeit nennt 32 Literaturangaben. Gefördert von: Tianjin Municipal Science and Technology Bureau, Tianjin Municipal Health Commission, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Whether LDCT-associated stage shift translates into similar survival patterns across lung cancer histologies remains uncertain. We compared stage shift, histological differentiation, tumor characteristics, and survival between lung squamous cell carcinoma (LUSC) and adenocarcinoma (LUAD) in the National Lung Screening Trial. METHODS: Among participants diagnosed with LUSC or LUAD, stage distribution and histological differentiation were compared between LDCT and chest X-ray (CXR) arms. Survival among diagnosed cases was measured from randomization. Multivariable models tested screening arm-by-histology interactions. Screen-detected LDCT tumors were compared by histology. RESULTS: During 6.5 years of median follow-up, 498 LUAD and 249 LUSC cases were diagnosed in the LDCT arm, and 374 and 212, respectively, were diagnosed in the CXR arm. LDCT was associated with higher odds of stage I disease for LUAD (adjusted odds ratio [aOR], 2.48; 95% CI 1.88-3.28) and LUSC (aOR, 1.71; 95% CI 1.17-2.48), without significant interaction (P = 0.116). LDCT was associated with lower hazard of lung cancer-specific death among diagnosed LUAD cases (adjusted hazard ratio [aHR], 0.54; 95% CI 0.43-0.66), but not among diagnosed LUSC cases (aHR, 1.04; 95% CI 0.78-1.39; P for interaction

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsCarcinoma, Squamous CellTomography, X-Ray ComputedAdenocarcinomaAdenocarcinoma of LungHumansFemaleMaleNeoplasm StagingMiddle AgedAgedEarly Detection of Cancer

Stichwörter der Autor:innen

AdenocarcinomaHistological differentiationLow-dose CTLung cancer screeningSquamous cell carcinomaStage shiftSurvival

Autor:innen und Institutionen

  • Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Tianjin Lung Cancer Institute, Tianjin Medical University General Hospital, Tianjin 300152, China; Department of Lung Cancer Surgery, Tianjin…
  • Department of Radiology, Tianjin Medical University General Hospital, Tianjin 300152, China.
  • National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
  • Department of Nuclear Medicine, Tianjin Medical University General Hospital, Tianjin 300152, China.
  • Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Tianjin Lung Cancer Institute, Tianjin Medical University General Hospital, Tianjin 300152, China; Sichuan Lung Cancer Institute, Sichuan Lung…
  • National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China; School of Population Medicine and Publi…

Förderung

  • Tianjin Municipal Science and Technology Bureau
  • Tianjin Municipal Health Commission
  • National Natural Science Foundation of China

Zitieren

APA

Fan, Y., Wang, Y., Li, X., Wu, H., Pan, H., Jiang, Y., Meng, Z., Wang, J., Chen, J., Zhou, Q., & Qiao, Y. (2026). Stage shift, histological differentiation, and survival patterns of lung squamous cell carcinoma versus adenocarcinoma in low-dose CT screening. Cancer Epidemiology. https://doi.org/10.1016/j.canep.2026.103197

Vancouver

Fan Y, Wang Y, Li X, Wu H, Pan H, Jiang Y, et al. Stage shift, histological differentiation, and survival patterns of lung squamous cell carcinoma versus adenocarcinoma in low-dose CT screening. Cancer Epidemiology. 2026. doi:10.1016/j.canep.2026.103197

BibTeX
@article{Fan2026,
  author = {Fan, Yaguang and Wang, Ying and Li, Xuebing and Wu, Heng and Pan, Hongli and Jiang, Yong and Meng, Zhaowei and Wang, Jing and Chen, Jun and Zhou, Qinghua and Qiao, Youlin},
  title = {Stage shift, histological differentiation, and survival patterns of lung squamous cell carcinoma versus adenocarcinoma in low-dose CT screening},
  journal = {Cancer Epidemiology},
  year = {2026},
  doi = {10.1016/j.canep.2026.103197}
}
Kostenlos starten →